Clinical Trial Update: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [Phase 3]

View source ↗

Summary

Phase 3 study comparing Viramidine to Ribavirin in treatment-naive patients with chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Viramidine (viramidine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED